Chiesi Group Reports Financial Results For 2005: Marked Growth Driven By The Pipeline Products
3/7/2006 6:32:27 PM
More...
|
Chiesi Farmaceutici SpA And Novartis Pharma AG (NVS) Sign International Licensing Agreement For Formoterol Modulite® HFA
10/19/2005 5:12:34 PM
More...
|
GB Therapeutics Ltd. Acquires Phase 3 Parkinson's Disease Molecule From Chiesi Farmaceutici SpA
10/19/2005 5:12:34 PM
More...
|
GB Therapeutics Ltd. Acquires License For A Phase 2 Neuropathic Pain molecule
10/19/2005 5:11:43 PM
More...
|